The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.86

Today's change-0.04 -2.11%
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.
 

Merus Labs International Inc

TSX: MSL
Delayed quote

$1.86

Today's change-0.04 -2.11%
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.

Merus Labs International Inc crosses below 125-day moving average

Merus Labs International Inc closed sharply lower Wednesday, dropping $0.04 or 2.11% to $1.86 and crossing below its 125-day moving average. Over the last five days, shares have lost 11.85% and are down 18.42% for the last year to date. This security has underperformed the S&P TSX by 21.07% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward190.00×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.01
Updated May 4 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1.73%

Merus Labs International Inc has a net profit margin of -1.73%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.55%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue16161013
Total other revenue--------
Total revenue16161013
Gross profit1112911
Total cost of revenue4411
Total operating expense1615109
Selling / general / administrative4333
Research & development--------
Depreciation / amortization7766
Interest expense (income), net operating--------
Unusual expense (income)00----
Other operating expenses, total--------
Operating income0104
Interest income (expense), net non-operating-1-2-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-2-12
Income after tax-1-1-22
Income tax, total0-100
Net income-1-1-22
Total adjustments to net income--------
Net income before extra. items-1-1-22
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-1-22
Inc. avail. to common incl. extra. items-1-1-22
Diluted net income-1-1-22
Dilution adjustment----00
Diluted weighted average shares1021029582
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.01-0.020.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.01-0.01-0.020.03